Search

Your search keyword '"Sogni, Philippe"' showing total 612 results

Search Constraints

Start Over You searched for: Author "Sogni, Philippe" Remove constraint Author: "Sogni, Philippe"
612 results on '"Sogni, Philippe"'

Search Results

1. International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations

2. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

4. Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors

6. WED-455 Sex disparities in initiation of direct-acting antivirals for hepatitis C treatment: data from the French national healthcare database (2014–2022, ANRS FANTASIO 2 study)

9. Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

10. Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease.

12. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

16. Contributing factors and outcomes of burn-associated cholestasis

17. Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors

22. Cannabis Use as a Protective Factor Against Overweight in HIV-Hepatitis C Virus Co-Infected People (ANRS CO13 HEPAVIH Cohort)

25. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort

27. Cardiac toxicity associated with pharmacokinetic drug–drug interaction between crizotinib and sofosbuvir/velpatasvir: A case report

28. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus–coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13–HEPAVIH Cohort

32. Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

33. Telaprevir for HIV/Hepatitis C Virus–Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial

34. Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

35. Risk of severe clinical events after sustained virological response following direct‐acting antiviral therapy in HIV and hepatitis C virus coinfected participants

36. Cardiac toxicity associated with pharmacokinetic drug–drug interaction between crizotinib and sofosbuvir/velpatasvir: a case report

38. Liver toxicities of immune checkpoints inhibitors for cancer: a multicenter retrospective study

43. Albumin Use in Patients With Cirrhosis in France: Results of the “ALBU-LIVE” Survey: A Case for Better EASL Guidelines Diffusion and/or Revision

45. Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study.

50. Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH)

Catalog

Books, media, physical & digital resources